Skip to content

The study of novel microbial markers for prostate cancer diagnosis

The study of novel microbial markers for prostate cancer diagnosis

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400084633
Enrollment
Unknown
Registered
2024-05-22
Start date
2024-05-21
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prostate cancer

Interventions

Index test:Through microbial diversity sequencing 16S rRNA and microbial metagenomic sequencing, the significant differences in microbial species, microbial abundance, correlation between relevant mic

Sponsors

Affiliated Hospital of North Sichuan Medical College
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
50 Years to 100 Years

Inclusion criteria

Inclusion criteria: ? According to the diagnostic guidelines of the Chinese Society of Urology, general risk patients aged 50 years or older who underwent PCa early screening were selected from the outpatient and inpatient departments of urology. ? All patients received blood prostate-specific antigen (PSA) and abdominal B-ultrasonography ? The diagnosis of prostate cancer and benign prostatic hyperplasia was confirmed by pathological examination of transrectal prostate biopsy guided by B-ultrasound or transurethral resection of the prostate combined with histopathological examination ? Patients were informed of the relevant trial procedures and signed informed consent

Exclusion criteria

Exclusion criteria: ? Previously received anti-androgenesis, castration, radiotherapy, chemotherapy and other treatments; Patients with other neoplastic diseases ? Contraindications of ultrasound-guided transrectal prostate biopsy: coagulation disorders and urogenital tract infection ? Patients who had previously received puncture biopsy and underwent related prostate surgery ? Received systemic antibiotic therapy (oral or intravenous) within 1 month before enrollment ? Patients who perform urethral operations such as catheterization or prostatic fluid examination within 1-2 weeks for prostate massage ? Patients who are under guardianship, supervision or are unable to give consent

Design outcomes

Primary

MeasureTime frame
Diagnostic relevance;Screening sensitivity;

Secondary

MeasureTime frame
accuracy;

Countries

China

Contacts

Public ContactTao Wu

Affiliated Hospital of North Sichuan Medical College

alhawking@163.com+86 180 1168 1306

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026